Arch Therapeutics, Inc. enterprise value

The Enterprise Value as of October 2026 (TTM) for Arch Therapeutics, Inc. (ARTH) is 5.41M

According to Arch Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.41M. This represents a change of -73.78% compared to the average of 20.62M of the last 4 quarters.

Arch Therapeutics, Inc. (ARTH) Historical Enterprise Value (quarterly & annually)

How has ARTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Arch Therapeutics, Inc. over the last ten years is 7.31B. The current 5.41M Enterprise Value has changed -99.93% with respect to the historical average. Over the past ten years (40 quarters), ARTH's Enterprise Value was at its highest in in the September 2017 quarter at 23.99B. The Enterprise Value was at its lowest in in the March 2023 quarter at 6.37M.

Arch Therapeutics, Inc. (ARTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arch Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arch Therapeutics, Inc. (ARTH) Average Enterprise Value

How has ARTH Enterprise Value performed in the past?

The current Enterprise Value of Arch Therapeutics, Inc. (ARTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Arch Therapeutics, Inc. (ARTH) Enterprise Value vs. Peers

How is ARTH’s Enterprise Value compared to its peers?

Arch Therapeutics, Inc.’s Enterprise Value is greater than Orchid Ventures, Inc. (-1002544.00), greater than Discover Wellness Solutions Inc. (66.43K), greater than Molecular Templates, Inc. (707.66K), less than Beleave Inc. (10.32M), less than ACI Global Corporation (0), less than MDEChem, Inc. (0), less than Micron Solutions, Inc. (5.59M), greater than Allena Pharmaceuticals, Inc. (-29461000.00), less than IMV Inc. (17.05M), greater than Mountain High Acquisitions Corp. (85.33K),

Build a custom stock screener for Arch Therapeutics, Inc. (ARTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arch Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arch Therapeutics, Inc. (ARTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arch Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.